Complex studies need a hands-on partner
Cell and gene therapies and other advanced therapeutics, with the senior attention they demand.
01
Experience with complex and novel modalities
Avion CRO supports cell and gene therapies and other advanced therapeutics: studies where standard playbooks do not apply and scientific judgement matters at every step.
02
Why complex studies suit a mid-sized partner
Advanced therapeutics programmes benefit from what a mid-sized, full-service CRO does best: senior attention throughout, flexible processes that adapt to the study rather than the other way around, and close, direct contact with the sponsor. The team who scopes your study stays on it.
03
The operational realities, handled
Cell and gene programmes bring demands beyond the protocol: specialised logistics, a limited pool of capable sites, and long-term follow-up requirements. These are planned for from feasibility, not discovered mid-study.
04
Regulatory support for novel modalities
Novel therapeutics raise novel regulatory questions. Avion CRO prepares and manages submissions for advanced therapeutics within the Australian pathway, so sponsors are never navigating the system alone.